drugset / Trial / NCT03809182

Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.

NCT03809182 ↗

Phase 4 Completed 40 enrolled Pontificia Universidad Catolica de Chile
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study investigated the effect of dexmedetomidine in obese patients undergoing bariatric surgery.

Timeline

Start
2012-09-27
Primary completion
2013-07-25
Completion
2013-07-25

Outcome

Mixed primary results

registry analysis (superiority test); Dexmedetomidine vs 0.9% Sodium-chloride; p = 0.38; Mixed Models Analysis NCT03809182 ↗

registry analysis (superiority test); Dexmedetomidine vs 0.9% Sodium-chloride; p = 0.02; Mixed Models Analysis NCT03809182 ↗

registry MEAN Dexmedetomidine: Hour 12 (T6): 16.6 (Standard Deviation 9.2) uU/dl NCT03809182 ↗

registry MEAN 0.9% Sodium-chloride: Hour 12 (T6): 25.9 (Standard Deviation 18.3) uU/dl NCT03809182 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg —
Background Fentanyl Other / unclassified 1 ug/kg —
Background Morphine Other / unclassified 3 mg Intravenous

Indications